Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy

被引:23
|
作者
Terwee, CB
Dekker, FW
Bonsel, GJ
Heisterkamp, SH
Prummel, MF
Baldeschi, L
Wiersinga, WM
机构
[1] VU Med Ctr, Inst Res Extramural Med, EMGO Inst, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Orbital Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1046/j.1365-2265.2003.01695.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The importance of facial disfigurement in many diseases necessitates a reliable and valid measure of disfigurement severity for clinical studies. The hypothesis is that a universal concept of disfigurement exists and can be measured in a reliable way. The objectives of this study were to investigate if persons, in particular patients and physicians, can agree on facial disfigurement severity; and to determine the relative contribution of predefined clinical characteristics of patients with Graves' ophthalmopathy (GO) to the overall rating of facial disfigurement severity. DESIGN A panel study was carried out in four different panels, each consisting of four members. PATIENTS We randomly selected 100 slide pairs of GO patients from four available study populations, involving mild, moderate and severe GO patients (mean age 49 years, 76% female) who were treated with either radiotherapy, sham-irradiation, prednisone or orbital decompression. MEASUREMENTS All panel members individually scored the disfigurement severity of 100 GO patients shown on standardized slides on a Visual Analog Scale. In total, 1600 ratings were collected. We calculated within- and between-panel agreement of disfigurement severity and identified determinants of disfigurement. RESULTS Agreement within a panel varied from 0.65 to 0.79 and was highest within the panel of ophthalmologists. Between-panel agreement was 0.67 and was highest between ophthalmologists and laypersons. Compared with the global average, patients overrated and endocrinologists underrated disfigurement severity. Female panellists rated the patients, on average, more disfigured than male panellists. Important determinants of disfigurement were eyelid retraction, severe eyelid swelling and proptosis. Their relative importance was consistent across panels and in contrast to current measures of GO severity. CONCLUSION Facial disfigurement severity can be measured in a reliable way using panels of panellists. Except for some systematic differences between panellists, facial disfigurement does not seem to be in the eye of the beholder.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [1] Investigation of eye micromovements in patients with Graves' ophthalmopathy
    Jankauskiene, J
    VISION RESEARCH, 1996, 36 : 350 - 350
  • [2] Graves' ophthalmopathy: eye muscle involvement in patients with diplopia
    Nagy, EV
    Toth, J
    Kaldi, I
    Damjanovich, J
    Mezosi, E
    Lenkey, A
    Toth, L
    Szabo, J
    Karanyi, Z
    Leovey, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (06) : 591 - 597
  • [3] Ophthalmopathy Consciousness Level in Graves Patients: Graves Ophthalmopathy
    Kan, Elif Kilic
    Kan, Emrah
    Ecemis, Gulcin Cengiz
    Bahadir, Cigdem Tura
    Colak, Ramis
    ERCIYES MEDICAL JOURNAL, 2014, 36 (03) : 104 - 107
  • [4] Characteristics of Dry Eye Syndrome in Patients with Mild Graves' Ophthalmopathy
    Bui, Giang Thi Huong
    Pham, Dong Ngoc
    Mai, Tung Quoc
    Pham, Van Trong
    OPEN OPHTHALMOLOGY JOURNAL, 2024, 18
  • [5] AN ANTIBODY TO EYE MUSCLE IN GRAVES OPHTHALMOPATHY
    KENDALLTAYLOR, P
    HOLCOMBE, M
    ATKINSON, S
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1640 - 1640
  • [6] AN ANTIBODY TO EYE MUSCLE IN GRAVES OPHTHALMOPATHY
    KENDALLTAYLOR, P
    ATKINSON, S
    HOLCOMBE, M
    QUARTERLY JOURNAL OF MEDICINE, 1984, 53 (212): : 528 - 529
  • [7] MEASURING EYE-MOVEMENTS IN GRAVES OPHTHALMOPATHY
    MOURITS, MP
    PRUMMEL, MF
    WIERSINGA, WM
    KOORNNEEF, L
    OPHTHALMOLOGY, 1994, 101 (08) : 1341 - 1346
  • [8] RELATIONSHIP OF EYE-MOVEMENT TO COMPUTED TOMOGRAPHIC FINDINGS IN PATIENTS WITH GRAVES OPHTHALMOPATHY
    CHEN, YL
    CHANG, TC
    HUANG, KM
    TZENG, SS
    KAO, SCS
    ACTA OPHTHALMOLOGICA, 1994, 72 (04): : 472 - 477
  • [9] Investigation of Meibomian Gland Function and Dry Eye Disease in Patients with Graves' Ophthalmopathy
    Inoue, Sachiko
    Kawashima, Motoko
    Arita, Reiko
    Kozaki, Ai
    Tsubota, Kazuo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 12
  • [10] THE CROSS REACTIVITIES OF EYE MUSCLE ANTIBODIES IN GRAVES OPHTHALMOPATHY
    JONES, D
    TAYLOR, P
    WEIGHTMAN, D
    KENDALLTAYLOR, P
    JOURNAL OF ENDOCRINOLOGY, 1987, 112 : 289 - 289